Cite

HARVARD Citation

    Fernandes, S. et al. (2020). Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease. Inflammatory bowel diseases. 26 (2), pp. 263-270. [Online]. 
  
Back to record